Capitol Hill Report
Advocacy
Read the Academy's bi-weekly update on legislative and regulatory advocacy for neurology.
June 9, 2025
Why member advocacy is ‘mission-critical’
We want to make sure you know we have your back. We’re actively responding, relentlessly pushing forward, and ensuring your voice is heard loud and clear on Capitol Hill. Please keep reading Capitol Hill Report—and tell your colleagues—for a rundown of how your AAN is in overdrive advocating on your behalf. We’re analyzing and monitoring all changes made by Congress and the administration to evaluate any impacts on neurology and the patients we serve. If your practice, research, or patients have been impacted by recent changes at the federal or state level, please let us know by emailing advocacy@aan.com.
Issue in focus
Last week, AAN Board Member José Posas, MD, FAAN, traveled to Washington, DC, to participate in the annual “House Call on the Mall,” where he represented neurology and helped elevate the voice of neurologists on Capitol Hill. During his time in DC, Posas met with key lawmakers and staff, participated in policy briefings, and engaged in strategic BrainPAC events to reinforce the importance of protecting access to quality neurological care.
Notably, Posas joined a health care policy roundtable, hosted by the GOP Doctors Caucus, where he was able to speak directly to lawmakers about the administrative burden facing neurologists. He also attended a policy briefing with Rep. Brett Guthrie (R-KY), chair of the House Energy and Commerce Committee, where he was able to share his personal experience treating patients as a neurologist. Throughout the trip, Posas effectively highlighted the value of neurology, emphasized the need for continued research funding and workforce support, and reinforced the AAN’s priorities to congressional leaders.

“Advocacy is mission-critical to the future of neurology,” Posas said. “If we’re not at the table helping shape the policies that impact our patients and our practices, then decisions will be made without us. Being in DC and speaking directly with lawmakers is one of the most powerful ways we can ensure neurology’s voice is heard and our priorities are advanced.”
Posas’ advocacy efforts demonstrate the significant impact that each AAN member can have on shaping federal policy and advancing the priorities of the neurology community. By actively engaging with lawmakers, sharing personal experiences, and participating in critical discussions, Posas exemplifies the collective power of AAN members to drive meaningful change at the national level.
Learn how you can get involved with AAN advocacy.
Latest advocacy news
AAN joins comments to promote patient access to appropriate epilepsy care
The AAN joined the National Association of Epilepsy Centers in urging the Centers for Medicare and Medicaid Services (CMS) to modify a proposal impacting payment for epilepsy with neurostimulator in the inpatient setting. The comments urge CMS to promote patient access to appropriate epilepsy care through assignment to MS-DRG 020.
AAN joins letter supporting investment in advanced Alternate Payment Models
The AAN joined a letter led by the National Association of ACOs asking Congress to support continued investment in Medicare’s transition to advanced Alternate Payment Models (APMs) that take on accountability for costs and outcomes of their patient populations.
What we're reading
-
11 million could lose insurance coverage: CBO ()
- A plan to preserve U.S. science leadership ()
- Budget for Veterans to See Private Doctors Would See Big Boost in GOP’s VA Funding Proposal ()
Past Capitol Hill Reports
2025
- May 27: House passes reconciliation bill
- May 12: President's proposed budget
- April 21: The state of Medicare and Medicaid
- April 7: AAN president highlights advocacy
- March 24: There’s a new chance to support neuroscience
- March 10: March 14 government funding deadline
- February 24: AAN members meet in Washington, DC
- February 11: Executive branch update
- January 20: New Congress, new plan
- January 6: Congress fails to address physician priorities
2024
- December 9: Key year-end issues
- November 25: Extending telehealth flexibilities
- November 11: What could fix physician reimbursement?
- October 21: Congressional lame-duck session
- October 7: Your advocacy impact
- September 23: Brain health for all!
- September 9: AAN comments on Medicare Fee Schedule
- August 26: Physicians are essential In local advocacy
- August 12: Ask Congress to take action for telehealth
- July 22: Urge Congress to prevent proposed cut
- July 8: Advocate for neurology from your home state!
- June 24: Crucial prior authorization bill introduced in Congress
- June 10: Senate group to discuss Medicare payment reform
- May 20: 30 years of Conrad 30
- May 6: Lobbyist for a Day
- April 22: Congress considers access to care
- April 8: AAN recommends more transparency in Medicare Advantage
- March 25: AAN identifies top advocacy priorities
- March 11: Congress acts on Medicare cuts
- February 26: Could your advocacy go even further at the state level?
- February 12: Neurology on the Hill preview
- January 22: Medicare reimbursement update
- January 8: 2023 Advocacy year in review
2023
- December 11: Take Action to Prevent Damaging Reimbursement Cuts!
- November 20: AAN Members Provide Perspective at AMA Meeting
- November 6: How Will the CMS Fee Schedule Affect You?
- October 23: Reps Hear Proposal to Cut 'Red Tape'
- October 9: Participant Goes from Training to Testimony
- September 25: AAN Leaders Take the Hill
- September 11: AAN Submits Comments on 2024 Medicare Physician Fee Schedule
- August 21: Proposed Code Will Help CMS Value Cognitive Care Services
- August 7: Reinforcements Are on the Way!
- July 24: AAN President Elect Testifies on New Alzheimer's Treatments
- July 10: FDA Approves Lecanemab for Alzheimer's Disease
- June 26: MACRA, Prior Authorization, and AMA Resolutions
- June 12: Debt Limit Deal Affects Dollars for Research
- May 22: Want Step Therapy Reform? Please Step Forward!
- May 8: Act Now to Protect Veteran Care, Medicare Reimbursement
- April 24: Do You Know the AAN's 2023 Advocacy Priority Issues?
- April 10: AAN Responds to Health Workforce Crisis Inquiry
- March 20: Working with CMS on Monoclonal Antibodies Coverage
- March 6: Support Your 180 Colleagues Now Advocating in DC
- February 20: Capitol Hill Report: AAN Addresses National, State Health Care Issues
- February 6: Confronting Prior Authorization Burden, End of PHE
- January 23: Advisory Committee Supports Medicare Reimbursement Increases
- January 9: Top AAN Advocacy Successes in 2022
2022
- December 23: Congress Enacts Bill with Key Advocacy Wins
- December 12: AAN Monitoring Lecanemab for Alzheimer's Disease
- November 21: How the Midterms Will Impact Neurology
- November 7: Advocacy Strengthens Neurology—Join Us!
- October 24: Urge Senate to Act on Medicare Payment Stability
- October 10: Get Involved in Neurology Advocacy
- September 26: Physician Lawmakers Seek to Stem Medicare Reductions
- September 12: AAN Comments on Proposed 2023 Medicare Physician Fee Schedule
- August 22: Administration Outlines Federal Response to Long COVID
- August 8: Congress Makes Progress on Neurology Issues
- July 25: AAN Urges Congress to Focus on Long COVID; Joined by 75 Organizations
- July 11: CMS Proposes Changes to Telehealth, E/M, QPP, More
- June 20: AAN Input Helps Shape AMA Policies
- June 6: Congressional Support Grows for Key AAN Legislation.
- May 23: It's Time for Neurology on the Hill!
- May 9: Focus Is on Three Issues for Neurology on the Hill
- April 25: Pushing Congress for More
- April 11: Congress Addressing AAN Priorities
- March 21: AAN Active on Legislation, Research Funding
- March 7: Members Make Their Advocacy Priorities Clear
- February 21: Legislation on Prior Authorization Gains Support
- February 7: Loosened Telehealth Policies in Peril
- January 24: COVID-19 Vaccinations, Aducanumab, and More
- January 10: Improving Care for Veterans With Neurological Conditions